Scientists probe why sepsis weakens the immune system
NCT ID NCT03788772
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study looks at how certain immune cells, called antigen-presenting cells, behave in people with sepsis—a life-threatening response to infection. Researchers collected blood samples from 119 participants, including sepsis patients, other ICU patients, and healthy volunteers. By analyzing these cells in detail, they hope to understand why sepsis can lead to further infections and poor outcomes.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this study could reveal how sepsis suppresses the immune system, pointing toward new ways to prevent secondary infections.
- What could go wrong
- This is an observational study, not a treatment trial. It may not lead to direct therapies, and findings may not apply to all sepsis patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE CIRCULATORY FAILURE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Cochin Hospital, AP-HP
Paris, 75014, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can we optimize antibiotic dosing for children with sepsis?
- Could starting feeds sooner shield preterm babies from infection?
- Can a temporary heart pump save more lives in cardiogenic shock?
- Can brain waves predict thinking problems after sepsis?
- Could starting dialysis sooner save more hearts?
- Can tailored nutrition boost recovery in the ICU?